Clinical Trial Update: Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting completion of a study evaluating Stilvid (resveratrol-enriched grape extract) for primary and secondary prevention of ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Stilvid (Resveratrol-enriched grape extract)

Snippet

Sponsor: National Research Council, Spain | Conditions: Cardiovascular Diseases | Phase 2 | Status: COMPLETED